(Q44697883)

English

Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial

scientific article published in December 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial (English)

1 reference

Europe PubMed Central

5 December 2017

vector-borne disease

0 references

phase II clinical trial

0 references

phase I clinical trial

0 references

1 reference

based on heuristic

inferred from title

Michael McDermott

2

object named as

Michael McDermott

0 references

author name string

Michael D Prados

1

1 reference

Europe PubMed Central

5 December 2017

Susan M Chang

3

1 reference

Europe PubMed Central

5 December 2017

Charles B Wilson

4

1 reference

Europe PubMed Central

5 December 2017

James Fick

5

1 reference

Europe PubMed Central

5 December 2017

Kenneth W Culver

6

1 reference

Europe PubMed Central

5 December 2017

John Van Gilder

7

1 reference

Europe PubMed Central

5 December 2017

G Evren Keles

8

1 reference

Europe PubMed Central

5 December 2017

Alex Spence

9

1 reference

Europe PubMed Central

5 December 2017

Mitchel Berger

10

1 reference

Europe PubMed Central

5 December 2017

publication date

1 December 2003

1 reference

Europe PubMed Central

5 December 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

5 December 2017

65

1 reference

Europe PubMed Central

5 December 2017

269-278

1 reference

Europe PubMed Central

5 December 2017

3

1 reference

Europe PubMed Central

5 December 2017

https://scigraph.springernature.com/pub.10.1023/b:neon.0000003588.18644.9c

0 references

Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy

1 reference

https://pubmed.ncbi.nlm.nih.gov/14682377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/14682377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/14682377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The basis for current treatment recommendations for malignant gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/14682377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/14682377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors

1 reference

https://pubmed.ncbi.nlm.nih.gov/14682377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14682377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene increases antitumor efficacy in vivo.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14682377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/14682377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14682377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MR of recurrent high-grade astrocytomas after intralesional immunotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14682377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect".

1 reference

https://pubmed.ncbi.nlm.nih.gov/14682377

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/B:NEON.0000003588.18644.9C

1 reference

Europe PubMed Central

5 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44697883&oldid=2032838214"